From: FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B
Stage > =2 (n = 15) n (%) or Mean (SD) | Stage < 2 (n = 30) n (%) or Mean (SD) | Univariable logistic regression | Multivariable logistic regression*** | ||||
---|---|---|---|---|---|---|---|
Variable | OR | 95% CI | p-value | p-value | |||
Age | 46.87 (13.93) | 40.17 (10.72) | 1.05 | 0.993; 1.110 | 0.089 | ||
Gender, N (%) | Male | 11 (42.31) | 15 (57.69) | 2.75 | 0.713; 10.605 | 0.1418 | 0.0641 |
Female* | 4 (21.05) | 15 (78.95) | |||||
Race, N (%) | Caucasian* | 1 (16.67) | 5 (83.33) | 0.2845 | |||
AA | 9 (50.00) | 9(50.00) | 5 | 0.483; 51.769 | |||
Asian | 4 (22.22) | 14 (77.78) | 1.429 | 0.127; 16.025 | |||
Other | 1 (33.33) | 2 (66.67) | 2.5 | 0.1; 62.602 | |||
Diagnosis | HBV | 7 (21.21) | 26 (78.79) | 0.135 | 0.031; 0.581 | 0.0072** | 0.0156** |
HIV/HBV* | 8 (66.67) | 4 (33.33) | |||||
Inflammation | Grade > 1 | 12 (57.14) | 9 (42.86) | 9.333 | 2.110; 41.278 | 0.0032** | 0.0066** |
Grade < =1* | 3 (12.50) | 21 (87.50) | |||||
FibroSURE | 0.462 (0.297) | 0.212 (0.167) | 3.015§ | 1.426; 6.374 | 0.0039** | 0.0158** | |
log10 ALT (U/L) | 1.81 (0.25) | 1.52 (0.28) | 3.314§ | 1.393; 7.883 | 0.0067** | ||
log10 AST (U/L) | 1.70 (0.21) | 1.51 (0.25) | 2.455§ | 1.065; 5.658 | 0.0350** | ||
log10 HBV DNA (IU/ml) | 5.24 (2.98) | 4.60 (2.39) | 1.304§ | 0.674; 2.520 | 0.4303 |